Varga, Tibor V.
Ali, Ashfaq
Herrera, Jose A. R.
Ahonen, Linda L.
Mattila, Ismo M.
Al-Sari, Naba H.
Legido-Quigley, Cristina
Skouby, Sven
Brunak, Søren
Tornberg, Åsa B.
Funding for this research was provided by:
Novo Nordisk Fonden (NNF16OC0020698, NNF14CC0001)
Kbenhavns Universitet
World Village of Women Sports Foundation
Arla Foods Ingredients
Article History
Received: 25 September 2019
Accepted: 23 January 2020
First Online: 11 February 2020
Competing interests
: S.B. has ownerships in Intomics A/S, Hoba Therapeutics Aps, Novo Nordisk A/S, Lundbeck A/S and managing board memberships in Proscion A/S and Intomics A/S. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.